sitagliptin glp 1 agonist GLP-1 receptor agonists or DPP-4 inhibitors: How to guide the clinician? Mechanism of action of GLP-1
Description
In the market, a large number of teams are developing therapeutic drugs targeting GLP-1R, GIPR, and GCGR
These insights provide a framework for precision medicine, where genetic profiling may help refine risk stratification and guide targeted therapeutic strategies
The drugs blunt the hit we get from these foods, and they start to lose their grip on us
& Morimoto, C
Lee, S.Y
